The Venture Codex Logo

The Venture Codex

Overview

Microbiome-based therapeutics for infectious disease prevention in livestoc

Total Raised

$7 M

Rounds

1

Links

Verticals

Analytics
Biotechnology
Therapeutics

Investment History

  1. Series A

    Jan 2021

    $7M

Team

Chris Belnap

Co-Founder and CEO

Greg Werner

Co-Founder, Chief Technology Officer

Todd DeSantis

Vice President of Bioinformatics

Rachelle Galvin

President & COO